MENU
DAWN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Day One Biopharmaceuticals (DAWN) Ownership - Who owns Day One Biopharmaceuticals?
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more
Profile
Industry
N/A
Address
2000 Sierra Point Parkway
Phone
+1 650 484-0899
Employees
155
Web
https://www.dayonebio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
624.83M
P/E Ratio
N/A
Total Cash
473.02M
Projected Growth
N/A
Total Debt
2.92M
Revenue
161.92M
Risk (Beta)
0.15
Dividend Yield
N/A
Total Cash/Share
4.62
Total Debt/Equity
N/A
Revenue/Share
1.85 USD as % of share price
Fundamentals
DAWN
Capitalization
625M
P/E Ratio
N/A
Risk (Beta)
0.15
Dividend Yield
N/A
Total Cash
473M
Total Cash/Share
4.62
Total Debt
2.92M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.85%
Revenue
162M
ROE
N/A
Book Value
480M
P/B Ratio
1.36
Cash Flow
N/A
Earnings
-0.65
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
10K
Current Ratio
10.62
Current Revenue Per Employee
169950.28
Dividends Per Share - Security
N/A
EBITDA
-188.76M
Float
N/A
Float - Current
N/A
Gross Income Margin
90.62
Revenue To Assets
-16.05
Shares Held By Institutions
1.03B
Shares Outstanding - Current
102M
Total Liabilities
54.8M
Total Volume MTD
N/A
Value
1
Gain YTD
-51.855
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. DAWN showed earnings on August 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2000 Sierra Point Parkway
Phone
+1 650 484-0899
Employees
155
Web
https://www.dayonebio.com